[Inflammatory breast cancer: clinical course, diagnosis and treatment].
To identify influence of different therapeutic and prognostic factors on survival, a review of the data on treatment of 197 patients with inflammatory breast cancer was carried out at the Dispensary (1994-2004). Multimodal treatment included combinations of radiotherapy, mastectomy and chemotherapy (CMF--75; CAF--98 and taxanes--9). Significantly lower survival was reported for patients with lymph node involvement (N1, N2 and N3) and those without mastectomy and radiotherapy. Overall 10-year survival was registered only in those who had received chemotherapy, radiotherapy and mastectomy (20.2% +/- 5.5); overall 5-year survival was 42.0% +/- 4.8.